HalioDx

company

About

HalioDx designs and develops diagnostic tests in oncology utilizing the immune contexture of cancers.

  • 51 - 100

Details

Last Funding Type
Series B
Last Funding Money Raised
€18.50M
Industries
Health Diagnostics,Medical,Pharmaceutical
Founded date
Jan 1, 2014
Number Of Employee
51 - 100
Operating Status
Active

HalioDx designs and develops diagnostic tests in oncology utilizing the immune contexture of cancers.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
€18.50M
HalioDx has raised a total of €18.50M in funding over 2 rounds. Their latest funding was raised on Jan 17, 2018 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 17, 2018 Series B €18.50M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
HalioDx is funded by 1 investors. PSIM fund are the most recent investors.
Investor Name Lead Investor Funding Round
PSIM fund Series B